KalVista Pharmaceuticals, Inc.(NasdaqGM:KALV) dropped from Russell Small Cap Comp Value Index
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.5 USD | -0.56% |
|
+6.66% | +2.04% |
07-11 | KalVista Pharmaceuticals Files $300 Million Mixed Shelf | MT |
07-11 | KalVista Pharmaceuticals, Inc. Reports Earnings Results for the Fourth Quarter Ended April 30, 2024 | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.04% | 527M | |
+6.96% | 98.81B | |
+7.24% | 42.32B | |
-8.49% | 34.48B | |
+83.65% | 29.83B | |
-12.97% | 15.93B | |
-0.80% | 14.01B | |
-12.22% | 11.52B | |
+173.60% | 10.45B | |
+5.99% | 9.06B |
- Stock Market
- Equities
- KALV Stock
- News KalVista Pharmaceuticals, Inc.
- KalVista Pharmaceuticals, Inc.(NasdaqGM: KALV) dropped from Russell Small Cap Comp Value Index